Enron Mail
From:
brown_mary_jo@lilly.com
To:
Subject:
ISIS 3521 Release
Cc:
Bcc:
Date:
Mon, 5 Nov 2001 12:56:27 -0800 (PST)
We thought you might be interested in this ISIS press release regarding the compound we are developing with ISIS for the treatment of non-small cell lung cancer.
- ISIS 3521 - AACR.NCI.EORTC Meeting - 10.29.doc